Delivery Order SPE2DB24D1205-SPE2DB25FDACG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $3,198.50, was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a contract ceiling value of $3,212.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a $5,486.24 delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single draw against AmerisourceBergen's existing contract vehicle with the Defense...
- The Defense Logistics Agency awarded a $3,914.17 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,570.58, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $8,389.85 and is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units) with a ceiling value of $3,122.46 and an ultimate completion date of July 31, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the Defense Logistics Agency. The contractor, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xeljanz 5 mg tablets (60-count units) with a ceiling value of $4,948.41. This firm fixed price delivery order, which is expected to be completed by August 19, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $4,335.80 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a firm fixed price contract type. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and was fulfilled at the vendor's location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a routine pharmaceutical procurement under the federal medical supply chain....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDACGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30 units, with a ceiling value of $92,797.95. This firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside procurement and is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor contract running through December 2026 that supports global military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement through the Defense Health Agency and other government healthcare systems. The Xeljanz XR supply supports the Defense Logistics Agency's pharmaceutical supply chain supporting military and veteran healthcare needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $92.8k | 9/3/25 |